Dissemination of a class i integron carrying VIM-2 carbapenemase in Pseudomonas Aeruginosa clinical isolates from a hospital intensive care unit in annaba Algeria

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2426-2427

  Touati, Meriem ^a,b   Diene, Seydina M ^a   Dekhil, Mazouz ^c   Djahoudi, Abdelghan ^b   Racherache, Abdelkari ^c   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b BADJI MOKHTAR UNIVERSITY   (Algeria)

^c Centre Hospitalier Universitaire de Annaba   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; IMIPENEM;

ADULT; ALGERIA; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATION; BRONCHUS BIOPSY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; INTEGRON; INTENSIVE CARE UNIT; LETTER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; URINALYSIS; VIM2 GENE; WOUND;

ADOLESCENT; ADULT; ALGERIA; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTEGRONS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84876224009     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00032-13     Document Type: Letter

References (18)

1. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-betalactamases: a last frontier for beta-lactams? Lancet Infect. Dis. 11:381-393.
2. Hammami S, Boutiba-Ben BI, Ghozzi R, Saidani M, Amine S, Ben RS. 2011. Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in a kidney transplantation unit. Diagn. Pathol. 6:106.
3. Ocampo-Sosa AA, Cabot G, Rodriguez C, Roman E, Tubau F, Macia MD, Moya B, Zamorano L, Suarez C, Pena C, Dominguez MA, Moncalian G, Oliver A, Martinez-Martinez L. 2012. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob. Agents Chemother. 56:1703-1713.
4. Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier JD, Rossolini GM. 2013. FIM-1, a new acquired metallo-beta-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob. Agents Chemother. 57:410-416.
5. Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
6. Giani T, Marchese A, Coppo E, Kroumova V, Rossolini GM. 2012. VIM-1-producing Pseudomonas mosselii isolates in Italy, predating known VIM-producing index strains. Antimicrob. Agents Chemother. 56:2216-2217.
7. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallobeta- lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
8. Ktari S, Mnif B, Znazen A, Rekik M, Mezghani S, Mahjoubi-Rhimi F, Hammami A. 2011. Diversity of beta-lactamases in Pseudomonas aeruginosa isolates producing metallo-beta-lactamase in two Tunisian hospitals. Microb. Drug Resist. 17:25-30.
9. Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmann P. 2009. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn. Microbiol. Infect. Dis. 64:458-461.
10. Diene SM, Bruder N, Raoult D, Rolain JM. 2011. Real-time PCR assay allows detection of the New Delhi metallo-beta-lactamase (NDM-1)- encoding gene in France. Int. J. Antimicrob. Agents 37:544-546.
11. Hammami S, Gautier V, Ghozzi R, Da CA, Ben-Redjeb S, Arlet G. 2010. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin. Microbiol. Infect. 16:189-193.
12. Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, Walsh TR. 2002. Molecular characterization of SPM-1, a novel metallo- beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J. Antimicrob. Chemother. 50: 673-679.
13. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. 2002. Imipenem-EDTA disk method for differentiation of metallo-betalactamase- producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801.
14. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649.
15. Szabo D, Szentandrassy J, Juhasz Z, Katona K, Nagy K, Rokusz L. 2008. Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumannii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary. Ann. Clin. Microbiol. Antimicrob. 7:12. doi:10.1186 /1476-0711-7-12.
16. Samuelsen O, Buaro L, Toleman MA, Giske CG, Hermansen NO, Walsh TR, Sundsfjord A. 2009. The first metallo-beta-lactamase identified in Norway is associated with a TniC-like transposon in a Pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana. Antimicrob. Agents Chemother. 53:331-332.
17. Pitout JD, Revathi G, Chow BL, Kabera B, Kariuki S, Nordmann P, Poirel L. 2008. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clin. Microbiol. Infect. 14:755-759.
18. Jacobson RK, Minenza N, Nicol M, Bamford C. 2012. VIM-2 metallobeta- lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa. J. Antimicrob. Chemother. 67:1797-1798.